MGSSHHHHHH SSGLVPRGSH MPEQSNDYRV VVFGAGGVGK SSLVLRFVKG TFRDTYIPTI EDTYRQVISC DKSVCTLQIT DTTGSHQFPA MQRLSISKGH AFILVFSVTS KQSLEELGPI YKLIVQIKGS VEDIPVMLVG KCDETQREV DTREAQAVAQ EWKCAFMETS AKMNYNVKEL FQELLTLETR RNMSLNIDGK RSGKQKRTDR KGKC.
DIRAS family, GTP-binding RAS-like 1 (DIRAS1), also known as Di-Ras1, is a member of the Ras superfamily of monomeric GTPases. This protein is encoded by the DIRAS1 gene in humans and is located on chromosome 19 (19p13.3) . DIRAS1 is known for its low GTPase activity and its predominant existence in the GTP-bound form .
DIRAS1 shares structural similarities with other members of the Ras superfamily, which are known for their role in intracellular signaling networks. However, DIRAS1 has unique amino acid substitutions in regions critical for GTP hydrolysis and interaction with RAF kinase, distinguishing it from other Ras proteins . These substitutions result in DIRAS1’s low GTPase activity and its predominant GTP-bound state .
The primary function of DIRAS1 is as a tumor suppressor. Unlike other Ras proteins that generally act as positive growth regulators, DIRAS1 inhibits cell growth and proliferation . This unique function is attributed to its structural differences and its role in regulating cell development in a manner distinct from other Ras family members .
DIRAS1 is highly expressed in heart and brain tissues . It is involved in various cellular processes, including signal transduction and the positive regulation of MAP kinase activity . The protein is localized to the plasma membrane, where it interacts with other signaling molecules to exert its effects .
DIRAS1 has been linked to several types of cancer, including glioblastoma, colorectal cancer, renal cell carcinoma, and ovarian cancer . Its role as a tumor suppressor makes it a potential target for cancer therapy. Understanding the mechanisms by which DIRAS1 inhibits cell growth could lead to the development of novel therapeutic strategies for cancer treatment.
Human recombinant DIRAS1 is produced using recombinant DNA technology, which involves inserting the DIRAS1 gene into a suitable expression system, such as bacteria or yeast, to produce the protein in large quantities. This recombinant protein can be used in various research applications, including studying its structure and function, investigating its role in cancer, and developing potential therapeutic agents.